Corona's nightmare is over
As you
sit at home, know the Japanese gift to the world and the latest treatment for
corona
The nightmare of the Corona
epidemic appears to be drawing to a close as many countries have recognized
promising and reassuring results that have proven the efficacy and efficacy of
the Japanese Avigan antiviral drug, known as Favipiravir, which works to trap
the Corona virus and convert results from positive to negative in just 4 days.
And the American magazine
Newsweek published a report that raises a state of optimism based on the
excellent, promising and reassuring results of the successful tests that have
been applied to 320 people infected with Corona virus in China by taking the Japanese
Avigan medicine, and these delightful results were the main motive for the
expansion of the use of the drug in Other countries such as Egypt, China and
the countries of the Middle East.
The results showed that people
who were treated with Favipiravir turned their results from positive to
negative after about four days, compared to 11 days for those who were not
given the drug, and X-rays also showed that more than 90% of patients treated
with Favipiravir saw an improvement In the case of lung, compared to 62% for
those who were not given the drug.
And today, Friday, April 10,
2020, the second stage of the clinical trial on Japanese avigan against Corona
has started, for about 50 patients with Corona in the United States of America,
through cooperation with Brigham and Women Hospital, Massachusetts General
Hospital, and the University of Massachusetts College of Medicine in America.
FUJIFILM Corporation announced
the start of a clinical trial in the second phase in the United States of
America to assess the safety, effectiveness and efficiency of avigan antiviral
drug for patients with coronavirus infection, according to the company
announced on its official website.
Avigan started its manufacture
and was put on the Japanese medicine market in 2014, knowing that the drug was
developed by Fujifilm Toyama Chemical Company of Japan, as it has been proven
effective against a number of RNA viruses, including influenza, West Nile
virus, and diseases Foot and mouth disease, yellow fever.
Avigan is officially approved
by the Japanese Ministry of Health, Labor and Social Welfare as an anti-viral
against influenza, as it selectively blocks the necessary RNA polymerase for
the spread of the influenza virus. For this reason, it is expected that the
avigan medicine will have a counter effect on the Corona virus because it is
like influenza viruses, especially since coronaviruses are RNA viruses Mono
Strip, also dependent on viral RNA polymerase.
Note that on March 31, 2020
FUJIFILM Corporation announced the start of the third phase of a clinical trial
of Avigan antiviral drug in patients with coronavirus in Japan.
FUJIFILM Corporation also
announced that it will continue to work quickly to find a cure for Covid-19
patients through clinical trials, and contribute to ending the spread of this
global epidemic as soon as possible by increasing the production of Avigan
antivirals.
RELATED TOPICS:
